Patent · US Active

Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells

US9850499B2 · kind B2 · utility

115Cited by
2References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 9, 2016
Grant dateDec 26, 2017
Priority date
Expiry dateSep 9, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/60
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A vector for generating induced pluripotent stem cells from human target cells comprising a) a vector backbone, b) exactly two, three or four transcription and reprogramming factor genes, each gene separated by a 2a self-cleavage peptide sequence, c) a spleen focus-forming virus promoter, and d) a post-transcriptional regulatory element Wpre, with or without an anti-apoptotic factor gene. A method for generating integration-free induced pluripotent stem cells, the method comprising: a) providing target cells, b) providing one or more than one vector according to the present invention, c) transducing or transfecting the target cells with the one or more than one vector, and d) culturing the transduced or transfected cells in a cell culture, thereby generating integration-free induced pluripotent stem cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.